Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Effects of nitric oxide inhibition on the spread of biotinylated dextran and on extracellular space parameters in the neostriatum of the male rat

A Jansson, T Mazel, B Andbjer, L Rosen, D Guidolin, M Zoli, E Sykova, LF Agnati, K Fuxe

. 1999 ; 91 (1) : 69-80.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc14055960

Grantová podpora
IZ3423 MZ0 CEP - Centrální evidence projektů

Digitální knihovna NLK
Plný text - Část
Zdroj

E-zdroje Online Plný text

NLK ScienceDirect (archiv) od 1993-01-01 do 2009-12-31

Volume transmission in the brain is mediated by the diffusion of neurotransmitters, modulators and other neuroactive substances in the extracellular space. The effects of nitric oxide synthase inhibition on extracellular space diffusion properties were studied using two different approaches, the histological dextran method and the real-time iontophoretic tetramethylammonium method. The spread of biotinylated dextran (mol. wt 3000) in the extracellular space was measured morphometrically following microinjection into the neostriatum of male rats. Two parameters were used to describe the spread of biotinylated dextran in brain tissue, namely, total volume of spread and the mean grey value. The nonspecific nitric oxide synthase inhibitors NG-nitro-L-arginine methyl ester (10-100 mg/kg) and NG-monomethyl-L-arginine acetate (30-200 mg/kg) decreased the total volume of spread of dextran in a dose-dependent manner. 7-Nitroindazole monosodium salt (50-100 mg/kg), a specific neuronal nitric oxide synthase inhibitor, did not change the total volume of spread of dextran. Using the tetramethylammonium method, the extracellular space diffusion properties can be described by the volume fraction (alpha = extracellular space volume/total tissue volume), tortuosity lambda (lambda2 = free diffusion coefficient/apparent diffusion coefficient in tissue), and non-specific uptake kappa' [Nicholson C. and Sykova E. (1998) Trends Neurosci. 21, 207-215]. Nitric oxide synthase inhibition by NG-nitro-L-arginine methyl ester (50 mg/kg) had relatively little effect on volume fraction and tortuosity, and no changes were observed after NG-monomethyl-L-arginine acetate (20 mg/kg) or 7-nitroindazole monosodium salt (100 mg/kg) treatment. A substantial increase was found only in non-specific uptake, by 13% after NG-nitro-L-arginine methyl ester and by 16% after NG-monomethyl-L-arginine acetate, which correlates with the decreased total volume of spread of dextran observed with the dextran method. NG-Nitro-L-arginine methyl ester treatment (100 mg/kg) decreased striatal blood flow and increased mean arterial blood pressure. The changes in dextran spread and non-specific uptake can be explained by an increased capillary clearance following the inhibition of endothelial nitric oxide synthase, as neuronal nitric oxide synthase inhibition had no effect. The observed changes after non-specific nitric oxide synthase inhibition may affect the extracellular space concentration of neurotransmitters and modulators, and influence volume transmission pathways in the central nervous system by increased capillary and/or cellular clearance rather than by changes in extracellular space diffusion.

000      
00000naa a2200000 a 4500
001      
bmc14055960
003      
CZ-PrNML
005      
20241204114030.0
007      
ta
008      
140414s1999 xxu f 000 0|eng||
009      
AR
035    __
$a (PubMed)10336061
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Jansson, A. $u Department of Neuroscience, Karolinska Institute, Stockholm, Sweden.
245    10
$a Effects of nitric oxide inhibition on the spread of biotinylated dextran and on extracellular space parameters in the neostriatum of the male rat / $c A Jansson, T Mazel, B Andbjer, L Rosen, D Guidolin, M Zoli, E Sykova, LF Agnati, K Fuxe
520    9_
$a Volume transmission in the brain is mediated by the diffusion of neurotransmitters, modulators and other neuroactive substances in the extracellular space. The effects of nitric oxide synthase inhibition on extracellular space diffusion properties were studied using two different approaches, the histological dextran method and the real-time iontophoretic tetramethylammonium method. The spread of biotinylated dextran (mol. wt 3000) in the extracellular space was measured morphometrically following microinjection into the neostriatum of male rats. Two parameters were used to describe the spread of biotinylated dextran in brain tissue, namely, total volume of spread and the mean grey value. The nonspecific nitric oxide synthase inhibitors NG-nitro-L-arginine methyl ester (10-100 mg/kg) and NG-monomethyl-L-arginine acetate (30-200 mg/kg) decreased the total volume of spread of dextran in a dose-dependent manner. 7-Nitroindazole monosodium salt (50-100 mg/kg), a specific neuronal nitric oxide synthase inhibitor, did not change the total volume of spread of dextran. Using the tetramethylammonium method, the extracellular space diffusion properties can be described by the volume fraction (alpha = extracellular space volume/total tissue volume), tortuosity lambda (lambda2 = free diffusion coefficient/apparent diffusion coefficient in tissue), and non-specific uptake kappa' [Nicholson C. and Sykova E. (1998) Trends Neurosci. 21, 207-215]. Nitric oxide synthase inhibition by NG-nitro-L-arginine methyl ester (50 mg/kg) had relatively little effect on volume fraction and tortuosity, and no changes were observed after NG-monomethyl-L-arginine acetate (20 mg/kg) or 7-nitroindazole monosodium salt (100 mg/kg) treatment. A substantial increase was found only in non-specific uptake, by 13% after NG-nitro-L-arginine methyl ester and by 16% after NG-monomethyl-L-arginine acetate, which correlates with the decreased total volume of spread of dextran observed with the dextran method. NG-Nitro-L-arginine methyl ester treatment (100 mg/kg) decreased striatal blood flow and increased mean arterial blood pressure. The changes in dextran spread and non-specific uptake can be explained by an increased capillary clearance following the inhibition of endothelial nitric oxide synthase, as neuronal nitric oxide synthase inhibition had no effect. The observed changes after non-specific nitric oxide synthase inhibition may affect the extracellular space concentration of neurotransmitters and modulators, and influence volume transmission pathways in the central nervous system by increased capillary and/or cellular clearance rather than by changes in extracellular space diffusion.
590    __
$a bohemika - dle Pubmed
650    02
$a zvířata $7 D000818
650    02
$a biotin $x analogy a deriváty $x aplikace a dávkování $x farmakokinetika $7 D001710
650    02
$a hematoencefalická bariéra $x účinky léků $7 D001812
650    02
$a mozkový krevní oběh $x účinky léků $7 D002560
650    02
$a dextrany $x aplikace a dávkování $x farmakokinetika $7 D003911
650    02
$a difuze $7 D004058
650    02
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    12
$a inhibitory enzymů $x farmakologie $7 D004791
650    02
$a extracelulární prostor $x enzymologie $x metabolismus $x účinky léků $7 D005110
650    02
$a fluorescenční barviva $7 D005456
650    02
$a gangliová stimulancia $x diagnostické užití $7 D005731
650    02
$a počítačové zpracování obrazu $7 D007091
650    02
$a indazoly $x farmakologie $7 D007191
650    02
$a mužské pohlaví $7 D008297
650    02
$a NG-nitroargininmethylester $x farmakologie $7 D019331
650    12
$a neostriatum $x enzymologie $x účinky léků $x ultrastruktura $7 D017072
650    02
$a proteiny nervové tkáně $x metabolismus $7 D009419
650    12
$a synthasa oxidu dusnatého $x antagonisté a inhibitory $x metabolismus $7 D019001
650    02
$a synthasa oxidu dusnatého, typ I $7 D052248
650    02
$a kvartérní amoniové sloučeniny $x diagnostické užití $7 D000644
650    02
$a krysa rodu Rattus $7 D051381
650    02
$a potkani Sprague-Dawley $7 D017207
650    02
$a časové faktory $7 D013997
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Mazel, Tomáš $7 xx0086098
700    1_
$a Andbjer, B. $7 gn_A_00005934
700    1_
$a Rosen, L.
700    1_
$a Guidolin, D.
700    1_
$a Zoli, M.
700    1_
$a Syková, Eva, $d 1944- $7 jn20000710633
700    1_
$a Agnati, L.F. $7 gn_A_00002193
700    1_
$a Fuxe, Kjell, $d 1938- $7 mzk20231210633
773    0_
$t Neuroscience $x 0306-4522 $g Roč. 91, č. 1 (1999), s. 69-80 $p Neuroscience $w MED00003505
910    __
$a ABA008 $b B 1931 $y 4 $z 0
990    __
$a 20140414092237 $b ABA008
991    __
$a 20241204114025 $b ABA008
999    __
$a ok $b bmc $g 1019553 $s 854552
BAS    __
$a 3
BMC    __
$a 1999 $b 91 $c 1 $d 69-80 $x MED00003505 $i 0306-4522 $m Neuroscience $n Neuroscience
GRA    __
$a IZ3423 $p MZ0
LZP    __
$a NLK 2014-04/lpbo

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...